Evok stock zacks
Jan 01, 2010 · Evoke Pharma (NASDAQ: EVOK) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Evoke Pharma, Inc. (EVOK) stock price, quote, history ... Find the latest Evoke Pharma, Inc. (EVOK) stock quote, history, news and other vital information to help you with your stock trading and investing. -$0.05 EPS Expected for Evoke Pharma Inc (NASDAQ:EVOK ... Zacks Investment Research cut shares of Evoke Pharma from a “strong-buy” rating to a “hold” rating in a research note on Saturday, January 4th. Finally, ValuEngine upgraded shares of Evoke Pharma from a “hold” rating to a “buy” rating in a research note on Friday, March 13th. Shares of EVOK stock opened at $1.01 on Monday. The
EVOK - Evoke Pharma Stock Price - Barchart.com
EVOK - Evoke Pharma Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. EVOK Stock News and Research Articles | Evoke Pharma ... EVOK Stock News and Research Articles - Evoke Pharma : latest news, headlines and research articles. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial Stock Down - www.zacks.com. EVOK - Evoke Pharma Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Evoke Pharma (NASDAQ: EVOK) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Evoke Pharma, Inc. (EVOK) stock price, quote, history ...
Evoke Pharma (NASDAQ: EVOK) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on
EVOK Stock News and Research Articles | Evoke Pharma ... EVOK Stock News and Research Articles - Evoke Pharma : latest news, headlines and research articles. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial Stock Down - www.zacks.com. EVOK - Evoke Pharma Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Evoke Pharma (NASDAQ: EVOK) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga.
Zacks provides the average brokerage recommendation (ABR) for thousands of stocks for most of the leading investment web sties. The ABR is the calculated average of the actual recommendations
According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.05. The reported EPS for the same Find the latest analyst research for Evoke Pharma, Inc. Common Stock (EVOK) at Nasdaq.com. Evoke Pharma (NASDAQ: EVOK) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on 20 Mar 2020 Real-time trade and investing ideas on Evoke Pharma EVOK from the largest community of traders and investors. 23 Nov 2019 Zacks Rank: This rating systems for stocks, mutual funds, and ETFs can point investors to investments they can potentially include in their own
Evoke Pharma, Inc. Common Stock (EVOK) Real-Time Stock ...
EVOK | Evoke Pharma Inc. Analyst Estimates | MarketWatch Nov 06, 2019 · Evoke Pharma Inc. analyst estimates by MarketWatch. View EVOK revenue estimates and earnings estimates, as well as analyst recommendations. EVOK News Today (Evoke Pharma) | MarketBeat View breaking news headlines for EVOK stock from trusted media outlets at MarketBeat. What's going on at Evoke Pharma (NASDAQ:EVOK)? View breaking news headlines for EVOK stock from trusted media outlets at MarketBeat. Sign up Log in . Zacks: Brokerages Anticipate Evoke Pharma Inc (NASDAQ:EVOK) to Announce -$0.06 Earnings Per Share EVOK (Evoke Pharma, Inc.) Stock Price and Chart - StockAP Zacks Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray, which is in Phase 2b clinical trials for the relief of symptoms associated with acute and recurrent diabetic EVOK - Evoke Pharma Stock Price - Barchart.com
Evoke Pharma's NDA Resubmission for Gimoti Gets FDA ... Jan 22, 2020 · Evoke Pharma, Inc. EVOK announced that the FDA has accepted its resubmission of 505(b)(2) new drug application (NDA) for the nasal spray product candidate, Gimoti. The company is seeking approval Evoke Pharma, Inc. (EVOK) Dividend Date & History - Nasdaq Feb 05, 2020 · See the upcoming ex dividend date and dividend history for Evoke Pharma, Inc. (EVOK). Stay alerted to dividend announcements for EVOK and all the companies you follow at NASDAQ.com EVOK - Evoke Pharma News - Barchart.com Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar. EVOK Stock | EVOKE PHARMA Stock Price Today | Markets Insider